Chemotherapy does not affect complication rate or patient satisfaction for breast reconstruction

Among those who underwent a mastectomy and breast reconstruction, there were no significant differences in complication rate or patient well-being for women who received chemotherapy as an additional treatment compared to those who did not.

11:00 AM

Author | Mary Clare Fischer

chemo medicine bags hanging on IV pole with lab note badge in yellow in background
Getty Images

Receiving chemotherapy as additional treatment for breast cancer did not increase the complication rate for women who underwent a mastectomy and a breast reconstruction as part of the same operation, University of Michigan researchers found.

Chemotherapy didn't affect the patients' well-being or their level of satisfaction with the procedure either.

The Mastectomy Reconstruction Outcomes Consortium Study is the first to examine this topic in a large number of patients at multiple health centers.

"One in eight women will be diagnosed with breast cancer during her lifetime, and the number of women undergoing mastectomy for breast cancer has increased over time," said Sarah E. Hart, M.D., the first author of the study and a plastic surgery resident at Michigan Medicine, the academic medical center of the University of Michigan. "The information from this study can assist patients and providers in informed decision making for breast reconstruction in the setting of chemotherapy."

Previous research led by Michigan Medicine has shown that radiation after breast reconstruction is linked to both higher complication rates and lower patient satisfaction.

Paper cited/DOI: "Impact of Chemotherapy on Clinical Complications and Patient-reported Outcomes after 1 Immediate Breast Reconstruction," JAMA Surgery.


More Articles About: Lab Notes Chemotherapy Reconstructive Surgery Post Operative and Recovery Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Health care provider with stethoscope holds patient's hand
Health Lab
Combatting prostate cancer stigma
Prostate cancer is highly treatable and over 98% of men survive 10 years if the cancer is diagnosed and treated early.
patient end of bed in hospital looking out window with stuffed animal on bed
Health Lab
Studying cells to improve medulloblastoma treatment
Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with an aggressive childhood cancer.
IV drip
Health Lab
Monitoring program flags cancer patients at risk of highly toxic chemotherapy side effects
Researchers from the University of Michigan Health Rogel Cancer Center have developed a monitoring system using a research genetics program to trigger alerts about cancer patients suspected to have the DPYD gene variant.
heart organ yellow blue
Health Lab
Older adults from distressed communities attend less cardiac rehab after heart procedures
Older adults who live in disadvantaged communities are less likely to attend cardiac rehabilitation after common heart procedures, a Michigan Medicine-led study finds.
cancer cell yellow blue
Health Lab
Potato starch supplements could be solution to bone marrow transplant complications
University of Michigan Health Rogel Cancer Center scientists have found a potential solution for preventing a common and dangerous complication in patients that receive stem cell transplants from a donor’s blood or bone marrow.  
older person pouring pills into hand close up
Health Lab
Early findings suggest this cancer drug may be effective against advanced tumors caused by genetic mutations
Sparrow Health System, part of University of Michigan Health, experts release findings in a study of a cancer drug for patients with genetic mutations.